top of page
News & Updates
Ilios selected as finalist for the Harvard President Innovation Challenge (Apr 2024)
Ilios Therapeutics has been selected as one of the five finalists for the Health and Life Science Harvard University President's Innovation Challenge!
We are grateful to the Harvard Innovation Labs, Harvard Life Lab and HBS Health Care Initiative for the support that is instrumental in propelling us toward our mission of generating multi-functional therapeutics to combat neurodegenerative diseases.
We invite you to join us for the grand finale on May 1st in Klarman Hall at Harvard Business School or through the online live stream. Let's celebrate this significant milestone together and also extend our support to the other remarkable entrepreneur finalists and semifinalists who are striving to make a difference in the world!
We are grateful to the Harvard Innovation Labs, Harvard Life Lab and HBS Health Care Initiative for the support that is instrumental in propelling us toward our mission of generating multi-functional therapeutics to combat neurodegenerative diseases.
We invite you to join us for the grand finale on May 1st in Klarman Hall at Harvard Business School or through the online live stream. Let's celebrate this significant milestone together and also extend our support to the other remarkable entrepreneur finalists and semifinalists who are striving to make a difference in the world!
Ilios to present at the 2024 MassBio Align Summit (Apr 2024)
At Ilios, we are thrilled to announce our participation in MassBio 2024 Align Summit organized in collaboration with McKinsey & Company and Locust Walk. We'll be showcasing our work on multi-targeted therapeutics against neurodegenerative diseases on April 25 at the Royal Sonesta Hotel. Join us for a day filled with partnering, keynotes, panel discussions and presentations from other innovative biotech companies.
Ilios attends JPM (Jan 2024)
Ilios's COO, Lisa Paborsky, and CEO, Luca Giani, attended the JPM 2024 Healthcare Conference in San Francisco. Among several productive meetings with potential partners and investors, Ilios was able to showcase its advancements towards a lead candidate selection for its ALS program.
Ilios to present at Bio Investor Forum in SF (Oct 2023)
Ilios to showcase drug development ALS program in partnering and venture funding BIO Investor Forum. Conference is focused on accelerating the progress of new therapeutic technologies.
Selected among HBS 2023-2024 Blavatnik Fellows (Jul 2023)
Ilios' CEO selected among the 2023-2024 cohort of Blavatnik Fellows. Celebrating its tenth anniversary, the Blavatnik Fellowship in Life Science Entrepreneurship selects five high-potential individuals from the Harvard MBA and PhD ecosystem.
bottom of page